Clinical Edge Journal Scan

Greater odds of metabolic syndrome and cardiovascular disease in PsA vs RA


 

Key clinical point: Patients with psoriatic arthritis (PsA) were more likely to have cardiovascular diseases (CVD) and metabolic syndrome (MS) than patients with rheumatoid arthritis (RA).

Major finding : MS (odds ratio [OR] 1.54; P = .002) and CVD (OR 6.13; P = .001) were more frequently observed in patients with PsA vs RA.

Study details : Findings are from a cross-sectional study including 197 patients with PsA and 279 patients with RA.

Disclosures: This study was supported by Peking University First Hospital, China, and other sources. The authors declared no conflict of interests.

Source: Li B et al. Discrepancy in metabolic syndrome between psoriatic arthritis and rheumatoid arthritis: A direct comparison of two cohorts in one center. Rheumatol Ther. 2022 (Oct 20). Doi: 10.1007/s40744-022-00502-4

Recommended Reading

Two biologics equally effective for extraintestinal manifestations of IBD
MDedge Rheumatology
Commentary: Drug efficacy and comorbid factors in PsA, November 2022
MDedge Rheumatology
Therapeutic drug monitoring pays off for arthritis patients
MDedge Rheumatology
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
MDedge Rheumatology
New ACR vaccination guideline: Take your best shot
MDedge Rheumatology
Long-term efficacy and safety of risankizumab in PsA patients with inadequate response to csDMARD
MDedge Rheumatology
Increased risk for preeclampsia in women with PsA
MDedge Rheumatology
Upadacitinib as effective and safe as adalimumab in the long term treatment of PsA
MDedge Rheumatology
Etanercept slows radiographic progression of PsA in the real world
MDedge Rheumatology
Higher prevalence of sonographic enthesitis in men than in women with PsA
MDedge Rheumatology